Topotecan Terminated Phase 2 Trials for Mediastinal Neoplasms Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00315211Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer